Skin diseases associated with the depletion of stratum corneum lipids and stratum corneum lipid substitution therapy

Skin Pharmacology and Physiology

Volumn 28, Issue 1, 2015, Pages 42-55

  Sahle, Fitsum F ^a,d   Gebre Mariam, Tsige ^d   Dobner, Bodo ^b   Wohlrab, Johannes ^c   Neubert, Reinhard H H ^a  

^a Departments Of Pharmaceutical Technology and Biopharmaceutics Institute of Pharmacy ^*  (Germany)

^b Institute of Pharmacy   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Ceramides; Cholesterol; Free fatty acids; Lipid replenishment therapy; Skin diseases; Stratum corneum

Indexed keywords

SKIN LIPID;

ARTICLE; ATOPIC DERMATITIS; DISEASE ASSOCIATION; HUMAN; IN VIVO STUDY; LIPID COMPOSITION; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN DISEASE; STRATUM CORNEUM; SUBSTITUTION THERAPY; ANIMAL; EPIDERMIS; LIPID METABOLISM; METABOLISM; SKIN DISEASES;

ANIMALS; EPIDERMIS; HUMANS; LIPID METABOLISM; SKIN DISEASES;

EID: 84920674291     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000360009     Document Type: Article

References (106)

1. El Maghraby GM, Barry BW, Williams AC: Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008; 34: 203-222.
2. Holleran WM, Takagi Y, Uchida Y: Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 2006; 580: 5456-5466.
3. Shah UU, Roberts M, Gul MO, Tuleu C, Beresford MW; NIHR MCRN/Arthritis Research UK Paediatric Rheumatology Clinical Studies Group: Needle-free and microneedle drug delivery in children: a case for diseasemodifying antirheumatic drugs (DMARDs). Int J Pharm 2011; 416: 1-11.
4. Bouwstra JA, Ponec M: The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006; 1758: 2080-2095.
5. Bonte F, Pinguet P, Chevalier JM, Meybeck A: Analysis of all stratum corneum lipids by automated multiple development high-performance thin-layer chromatography. J Chromatogr B Biomed Appl 1995; 664: 311-316.
6. Bonte F, Pinguet P, Saunois A, Meybeck A, Beugin S, Ollivon M, Lesieur S: Thermotropic phase behavior of in vivo extracted human stratum corneum lipids. Lipids 1997; 32: 653-660.
7. Ponec M, Weerheim A, Lankhorst P, Wertz P: New acylceramide in native and reconstructed epidermis. J Invest Dermatol 2003; 120: 581-588.
8. de Jager MW, Gooris GS, Dolbnya IP, Bras W, Ponec M, Bouwstra JA: The phase behaviour of skin lipid mixtures based on synthetic ceramides. Chem Phys Lipids 2003; 124: 123-134.
9. Hatfield RM, Fung LW: Molecular properties of a stratum corneum model lipid system: large unilamellar vesicles. Biophys J 1995; 68: 196-207.
10. Groen D, Gooris GS, Ponec M, Bouwstra JA: Two new methods for preparing a unique stratum corneum substitute. Biochim Biophys Acta 2008; 1778: 2421-2429.
11. Ishikawa J, Shimotoyodome Y, Chen S, Ohkubo K, Takagi Y, Fujimura T, Kitahara T, Takema Y: Eucalyptus increases ceramide levels in keratinocytes and improves stratum corneum function. Int J Cosmet Sci 2012; 34: 17-22.
12. Zhang L, Hellgren LI, Xu X: Enzymatic production of ceramide from sphingomyelin. J Biotechnol 2006; 123: 93-105.
13. Farwanah H, Raith K, Neubert RH, Wohlrab J: Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin. Arch Dermatol Res 2005; 296: 514-521.
14. Lampe MA, Williams ML, Elias PM: Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res 1983; 24: 131-140.
15. Proksch E, Jensen JM, Elias PM: Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol 2003; 21: 134-144.
16. Weerheim A, Ponec M: Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thin-layer chromatography. Arch Dermatol Res 2001; 293: 191-199.
17. Loden M: The skin barrier and use of moisturizers in atopic dermatitis. Clin Dermatol 2003; 21: 145-157.
18. Mizutani Y, Mitsutake S, Tsuji K, Kihara A, Igarashi Y: Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 2009; 91: 784-790.
19. de Jager MW, Gooris GS, Dolbnya IP, Ponec M, Bouwstra JA: Modelling the stratum corneum lipid organisation with synthetic lipid mixtures: the importance of synthetic ceramide composition. Biochim Biophys Acta 2004; 1664: 132-140.
20. Kang L, Ho PC, Chan SY: Interactions between a skin penetration enhancer and the main components of human stratum corneum lipids isothermal titration calorimetry study. J Therm Anal Calorim 2006; 83: 27-30.
21. Hatta I, Ohta N, Inoue K, Yagi N: Coexistence of two domains in intercellular lipid matrix of stratum corneum. Biochim Biophys Acta 2006; 1758: 1830-1836.
22. de Jager MW, Gooris GS, Dolbnya IP, Bras W, Ponec M, Bouwstra JA: Novel lipid mixtures based on synthetic ceramides reproduce the unique stratum corneum lipid organization. J Lipid Res 2004; 45: 923-932.
23. Norlen L, Gil IP, Simonsen A, Descouts P: Human stratum corneum lipid organization as observed by atomic force microscopy on Langmuir-Blodgett films. J Struct Biol 2007; 158: 386-400.
24. Bonte F, Saunois A, Pinguet P, Meybeck A: Existence of a lipid gradient in the upper stratum corneum and its possible biological significance. Arch Dermatol Res 1997; 289: 78-82.
25. Joo KM, Nam GW, Park SY, Han JY, Jeong HJ, Lee SY, Kim HK, Lim KM: Relationship between cutaneous barrier function and ceramide species in human stratum corneum. J Dermatol Sci 2010; 60: 47-50.
26. Jungersted JM, Hogh JK, Hellgren LI, Jemec GBE, Agner T: Ethnicity and stratum corneum ceramides. Br J Dermatol 2010; 163: 1169-1173.
27. Norlen L, Nicander I, Lundh Rozell B, Ollmar S, Forslind B: Inter- and intra-individual differences in human stratum corneum lipid content related to physical parameters of skin barrier function in vivo. J Invest Dermatol 1999; 112: 72-77.
28. Masukawa Y, Narita H, Shimizu E, Kondo N, Sugai Y, Oba T, Homma R, Ishikawa J, Takagi Y, Kitahara T, Takema Y, Kita K: Characterization of overall ceramide species in human stratum corneum. J Lipid Res 2008; 49: 1466-1476.
29. van Smeden J, Hoppel L, van der Heijden R, Hankemeier T, Vreeken RJ, Bouwstra JA: LC/ MS analysis of stratum corneum lipids: ceramide profiling and discovery. J Lipid Res 2011; 52: 1211-1221.
30. t'Kindt R, Jorge L, Dumont E, Couturon P, David F, Sandra P, Sandra K: Profiling and characterizing skin ceramides using reversedphase liquid chromatography-quadrupole time-of-flight mass spectrometry. Anal Chem 2012; 84: 403-411.
31. Farwanah H, Wohlrab J, Neubert RH, Raith K: Profiling of human stratum corneum ceramides by means of normal phase LC/APCIMS. Anal Bioanal Chem 2005; 383: 632-637.
32. Ramesh G, Das UN: Effect of free fatty acids on two-stage skin carcinogenesis in mice. Cancer Lett 1996; 100: 199-209.
33. Ziboh VA, Miller CC, Cho Y: Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. Am J Clin Nutr 2000; 71: 361S-366S.
34. Hinder A, Schmelzer CEH, Rawlings AV, Neubert RHH: Investigation of the molecular structure of the human stratum corneum ceramides [NP] and [EOS] by mass spectrometry. Skin Pharmacol Physiol 2011; 24: 127-135.
35. Ansari MNA, Nicolaides N, Fu HC: Fatty acid composition of the living layer and stratum corneum lipids of human sole skin epidermis. Lipids 1970; 5: 838-845.
36. Terashi H, Izumi K, Rhodes LM, Marcelo CL: Human stratified squamous epithelia differ in cellular fatty acid composition. J Dermatol Sci 2000; 24: 14-24.
37. Jiang WG, Bryce RP, Horrobin DF: Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol 1998; 27: 179-209.
38. Takigawa H, Nakagawa H, Kuzukawa M, Mori H, Imokawa G: Deficient production of hexadecanoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus . Dermatology 2005; 211: 240-248.
39. Chen X, Kwak S, Lafleur M, Bloom M, Kitson N, Thewalt J: Fatty acids influence 'solid' phase formation in models of stratum corneum intercellular membranes. Langmuir 2007; 23: 5548-5556.
40. Brody I: A light and electron microscopy study of normal human stratum corneum with particular reference to the intercellular space. Ups J Med Sci 1989; 94: 29-45.
41. Bouwstra JA, Dubbelaar FE, Gooris GS, Ponec M: The lipid organisation in the skin barrier. Acta Derm Venereol Suppl (Stockh) 2000; 208: 23-30.
42. Forslind B: A domain mosaic model of the skin barrier. Acta Derm Venereol 1994; 74: 1-6.
43. Kiselev MA, Ryabova NY, Balagurov AM, Dante S, Hauss T, Zbytovska J, Wartewig S, Neubert RH: New insights into the structure and hydration of a stratum corneum lipid model membrane by neutron diffraction. Eur Biophys J 2005; 34: 1030-1040.
44. ten Grotenhuis E, Demel RA, Ponec M, Boer DR, van Miltenburg JC, Bouwstra JA: Phase behavior of stratum corneum lipids in mixed Langmuir-Blodgett monolayers. Biophys J 1996; 71: 1389-1399.
45. Schroter A, Kessner D, Kiselev MA, Hauss T, Dante S, Neubert RH: Basic nanostructure of stratum corneum lipid matrices based on ceramides [EOS] and [AP]: a neutron diffraction study. Biophys J 2009; 97: 1104-1114.
46. Norlen L: Skin barrier structure and function: the single gel phase model. J Invest Dermatol 2001; 117: 830-836.
47. Kiselev MA: Conformation of ceramide 6 molecules and chain-flip transitions in the lipid matrix of the outermost layer of mammalian skin, the stratum corneum. Crystallogr Rep 2007; 52: 525-528.
48. Kessner D, Ruettinger A, Kiselev MA, Wartewig S, Neubert RH: Properties of ceramides and their impact on the stratum corneum structure. Part 2. Stratum corneum lipid model systems. Skin Pharmacol Physiol 2008; 21: 58-74.
49. Norlen L: Molecular structure of the SC lipids in vivo. Skin Forum 12th Ann Meet, Frankfurt, 2011.
50. Boncheva M, Damien F, Normand V: Molecular organization of the lipid matrix in intact stratum corneum using ATR-FTIR spectroscopy. Biochim Biophys Acta 2008; 1778: 1344-1355.
51. Caussin J, Gooris GS, Bouwstra JA: FTIR studies show lipophilic moisturizers to interact with stratum corneum lipids, rendering the more densely packed. Biochim Biophys Acta 2008; 1778: 1517-1524.
52. Bouwstra JA, Honeywell-Nguyen PL: Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 2002; 54(suppl 1):S41-S55.
53. Caussin J, Gooris GS, Janssens M, Bouwstra JA: Lipid organization in human and porcine stratum corneum differs widely, while lipid mixtures with porcine ceramides model human stratum corneum lipid organization very closely. Biochim Biophys Acta 2008; 1778: 1472-1482.
54. Corbe E, Laugel C, Yagoubi N, Baillet A: Role of ceramide structure and its microenvironment on the conformational order of model stratum corneum lipids mixtures: an approach by FTIR spectroscopy. Chem Phys Lipids 2007; 146: 67-75.
55. Hong KK, Cho HR, Ju WC, Cho Y, Kim NI: A study on altered expression of serine palmitoyltransferase and ceramidase in psoriatic skin lesion. J Korean Med Sci 2007; 22: 862-867.
56. Popa I, Bennaceur K, Abdul-Malak N, Perrier E, Schmitt D, Portoukalian J: Studies of compounds that enhance sphingolipid metabolism in human keratinocytes. Int J Cosmet Sci 2006; 28: 53-59.
57. Uchida Y, Hara M, Nishio H, Sidransky E, Inoue S, Otsuka F, Suzuki A, Elias PM, Holleran WM, Hamanaka S: Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 2000; 41: 2071-2082.
58. Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E: Consequences of β-glucocerebrosidase deficiency in epidermis: ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994; 93: 1756-1764.
59. Alessandrini F, Stachowitz S, Ring J, Behrendt H: The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris. J Invest Dermatol 2001; 116: 394-400.
60. Imokawa G: A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. J Dermatol Sci 2009; 55: 1-9.
61. Holleran WM, Gao WN, Feingold KR, Elias PM: Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements. Arch Dermatol Res 1995; 287: 254-258.
62. Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM: Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993; 91: 1656-1664.
63. Grubauer G, Elias PM, Feingold KR: Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 1989; 30: 323-333.
64. Proksch E, Elias PM, Feingold KR: Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis: modulation of enzyme content and activation state by barrier requirements. J Clin Invest 1990; 85: 874-882.
65. Mao-Qiang M, Elias PM, Feingold KR: Fatty acids are required for epidermal permeability barrier function. J Clin Invest 1993; 92: 791-798.
66. Feingold KR, Man MQ, Menon GK, Cho SS, Brown BE, Elias PM: Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest 1990; 86: 1738-1745.
67. Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR: Sphingolipids are required for mammalian epidermal barrier function: inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 1991; 88: 1338-1345.
68. Mao-Qiang M, Feingold KR, Elias PM: Inhibition of cholesterol and sphingolipid synthesis causes paradoxical effects on permeability barrier homeostasis. J Invest Dermatol 1993; 101: 185-190.
69. Lew BL, Cho Y, Kim J, Sim WY, Kim NI: Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-α, and JNK. J Korean Med Sci 2006; 21: 95-99.
70. Jacobs RJ: Depleted skin barrier replenishing skin creams composition and method of application. US Patent No US 10/426,493. 2004.
71. Grubauer G, Feingold KR, Harris RM, Elias PM: Lipid content and lipid type as determinants of the epidermal permeability barrier. J Lipid Res 1989; 30: 89-96.
72. Kwak S, Brief E, Langlais D, Kitson N, Lafleur M, Thewalt J: Ethanol perturbs lipid organization in models of stratum corneum membranes: an investigation combining differential scanning calorimetry, infrared and 2 H NMR spectroscopy. Biochim Biophys Acta 2012; 1818: 1410-1419.
73. Imokawa G, Akasaki S, Minematsu Y, Kawai M: Importance of intercellular lipids in waterretention properties of the stratum corneum: induction and recovery study of surfactant dry skin. Arch Dermatol Res 1989; 281: 45-51.
74. Jenerowicz D, Silny W, Danczak-Pazdrowska A, Polanska A, Osmola-Mankowska A, Olek-Hrab K: Environmental factors and allergic diseases. Ann Agric Environ Med 2012; 19: 475-481.
75. Rawlings AV, Matts PJ: Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle. J Invest Dermatol 2005; 124: 1099-1110.
76. Rogers J, Harding C, Mayo A, Banks J, Rawlings A: Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res 1996; 288: 765-770.
77. Both DM, Goodtzova K, Yarosh DB, Brown DA: Liposome-encapsulated ursolic acid increases ceramides and collagen in human skin cells. Arch Dermatol Res 2002; 293: 569-575.
78. Jin K, Higaki Y, Takagi Y, Higuchi K, Yada Y, Kawashima M, Imokawa G: Analysis of β-glucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol 1994; 74: 337-340.
79. Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD: Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol 2001; 117: 309-317.
80. Al'Abadie MS, Kent GG, Gawkrodger DJ: The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994; 130: 199-203.
81. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R: Slowing of wound healing by psychological stress. Lancet 1995; 346: 1194-1196.
82. Gupta MA, Gupta AK: Psychodermatology: an update. J Am Acad Dermatol 1996; 34: 1030-1046.
83. Marucha PT, Kiecolt-Glaser JK, Favagehi M: Mucosal wound healing is impaired by examination stress. Psychosom Med 1998; 60: 362-365.
84. Vavrova K, Zbytovska J, Palat K, Holas T, Klimentova J, Hrabalek A, Dolezal P: Ceramide analogue 14S24 ((S)-2-tetracosanoylamino- 3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro. Eur J Pharm Sci 2004; 21: 581-587.
85. Farwanah H, Neubert R, Zellmer S, Raith K: Improved procedure for the separation of major stratum corneum lipids by means of automated multiple development thin-layer chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 780: 443-450.
86. Ishikawa J, Narita H, Kondo N, Hotta M, Takagi Y, Masukawa Y, Kitahara T, Takema Y, Koyano S, Yamazaki S, Hatamochi A: Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol 2010; 130: 2511-2514.
87. Macheleidt O, Kaiser HW, Sandhoff K: Deficiency of epidermal protein-bound ω-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002; 119: 166-173.
88. Cho Y, Lew BL, Seong K, Kim NI: An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis. J Korean Med Sci 2004; 19: 859-863.
89. Holleran WM, Feingold KR, Man MQ, Gao WN, Lee JM, Elias PM: Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 1991; 32: 1151-1158.
90. Menon GK, Feingold KR, Elias PM: Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992; 98: 279-289.
91. Yang L, Mao-Qiang M, Taljebini M, Elias PM, Feingold KR: Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment. Br J Dermatol 1995; 133: 679-685.
92. Stover TC, Sharma A, Robertson GP, Kester M: Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 2005; 11: 3465-3474.
93. Chung S, Kong S, Seong K, Cho Y: γ-Linolenic acid in borage oil reverses epidermal hyperproliferation in guinea pigs. J Nutr 2002; 132: 3090-3097.
94. Barre DE: Potential of evening primrose, borage, black currant, and fungal oils in human health. Ann Nutr Metab 2001; 45: 47-57.
95. Bellew S, del Rosso JQ: Overcoming the barrier treatment of ichthyosis: a combinationtherapy approach. J Clin Aesthet Dermatol 2010; 3: 49-53.
96. Vavrova K, Hrabalek A, Mac-Mary S, Humbert P, Muret P: Ceramide analogue 14S24 selectively recovers perturbed human skin barrier. Br J Dermatol 2007; 157: 704-712.
97. Man MM, Feingold KR, Thornfeldt CR, Elias PM: Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol 1996; 106: 1096-1101.
98. Sahle FF, Metz H, Wohlrab J, Neubert RH: Polyglycerol fatty acid ester surfactantbased microemulsions for targeted delivery of ceramide AP into the stratum corneum: formulation, characterisation, in vitro release and penetration investigation. Eur J Pharm Biopharm 2012; 82: 139-150.
99. Sahle FF, Metz H, Wohlrab J, Neubert RH: Lecithin-based microemulsions for targeted delivery of ceramide AP into the stratum corneum: formulation, characterizations, and in vitro release and penetration studies. Pharm Res 2013; 30: 538-551.
100. Sahle FF, Wohlrab J, Neubert RH: Controlled penetration of ceramides into and across the stratum corneum using various types of microemulsions and formulation associated toxicity studies. Eur J Pharm Biopharm 2014; 86: 244-250.
101. Kato E, Takahashi N: Improvement by sodium dl-α-tocopheryl-6-O-phosphate treatment of moisture-retaining ability in stratum corneum through increased ceramide levels. Bioorg Med Chem 2012; 20: 3837-3842.
102. Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S: Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol 2000; 143: 524-531.
103. Rawlings AV, Davies A, Carlomusto M, Pillai S, Zhang K, Kosturko R, Verdejo P, Feinberg C, Nguyen L, Chandar P: Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res 1996; 288: 383-390.
104. Dahl MV, Dahl AC: 12% lactate lotion for the treatment of xerosis: a double-blind clinical evaluation. Arch Dermatol 1983; 119: 27-30.
105. Nakahara M, Mishima T, Hayakawa T: Effect of a sake concentrate on the epidermis of aged mice and confirmation of ethyl α- D - glucoside as its active component. Biosci Biotechnol Biochem 2007; 71: 427-434.
106. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R: Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1993; 1182: 147-151.